S&P 500   3,354.53 (-0.93%)
DOW   29,088.25 (-0.89%)
QQQ   232.99 (-1.68%)
AAPL   319.25 (-1.35%)
FB   213.74 (-1.72%)
MSFT   182.59 (-2.50%)
GOOGL   1,506.57 (-1.20%)
AMZN   2,135.57 (-1.60%)
CGC   22.53 (+3.49%)
NVDA   304.89 (-3.12%)
BABA   216.35 (-2.61%)
MU   58.41 (-2.63%)
GE   12.51 (-0.79%)
AMD   56.82 (-3.53%)
T   38.44 (+0.00%)
ACB   1.69 (-1.17%)
F   8.03 (+0.38%)
NFLX   380.45 (-1.49%)
BAC   34.73 (+0.03%)
DIS   139.18 (-1.50%)
S&P 500   3,354.53 (-0.93%)
DOW   29,088.25 (-0.89%)
QQQ   232.99 (-1.68%)
AAPL   319.25 (-1.35%)
FB   213.74 (-1.72%)
MSFT   182.59 (-2.50%)
GOOGL   1,506.57 (-1.20%)
AMZN   2,135.57 (-1.60%)
CGC   22.53 (+3.49%)
NVDA   304.89 (-3.12%)
BABA   216.35 (-2.61%)
MU   58.41 (-2.63%)
GE   12.51 (-0.79%)
AMD   56.82 (-3.53%)
T   38.44 (+0.00%)
ACB   1.69 (-1.17%)
F   8.03 (+0.38%)
NFLX   380.45 (-1.49%)
BAC   34.73 (+0.03%)
DIS   139.18 (-1.50%)
S&P 500   3,354.53 (-0.93%)
DOW   29,088.25 (-0.89%)
QQQ   232.99 (-1.68%)
AAPL   319.25 (-1.35%)
FB   213.74 (-1.72%)
MSFT   182.59 (-2.50%)
GOOGL   1,506.57 (-1.20%)
AMZN   2,135.57 (-1.60%)
CGC   22.53 (+3.49%)
NVDA   304.89 (-3.12%)
BABA   216.35 (-2.61%)
MU   58.41 (-2.63%)
GE   12.51 (-0.79%)
AMD   56.82 (-3.53%)
T   38.44 (+0.00%)
ACB   1.69 (-1.17%)
F   8.03 (+0.38%)
NFLX   380.45 (-1.49%)
BAC   34.73 (+0.03%)
DIS   139.18 (-1.50%)
S&P 500   3,354.53 (-0.93%)
DOW   29,088.25 (-0.89%)
QQQ   232.99 (-1.68%)
AAPL   319.25 (-1.35%)
FB   213.74 (-1.72%)
MSFT   182.59 (-2.50%)
GOOGL   1,506.57 (-1.20%)
AMZN   2,135.57 (-1.60%)
CGC   22.53 (+3.49%)
NVDA   304.89 (-3.12%)
BABA   216.35 (-2.61%)
MU   58.41 (-2.63%)
GE   12.51 (-0.79%)
AMD   56.82 (-3.53%)
T   38.44 (+0.00%)
ACB   1.69 (-1.17%)
F   8.03 (+0.38%)
NFLX   380.45 (-1.49%)
BAC   34.73 (+0.03%)
DIS   139.18 (-1.50%)
Log in

NASDAQ:MIST - Milestone Pharmaceuticals Stock Price, Forecast & News

$20.73
-0.21 (-1.00 %)
(As of 02/20/2020 12:53 PM ET)
Today's Range
$20.69
Now: $20.73
$21.00
50-Day Range
$16.00
MA: $19.66
$22.50
52-Week Range
$12.36
Now: $20.73
$27.95
Volume2,294 shs
Average Volume53,765 shs
Market Capitalization$507.79 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes drugs for the treatment of cardiovascular indications. It offers Etripamil that completed Phase 2 clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for treating Atrial Fibrillation and Angina. The company was founded in 2003 and is headquartered in Montréal, Canada.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MIST
CUSIPN/A
CIKN/A
Phone514-336-0444

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Net Income$-23,180,000.00

Miscellaneous

Employees20
Market Cap$507.79 million
Next Earnings Date2/26/2020 (Estimated)
OptionableNot Optionable

Receive MIST News and Ratings via Email

Sign-up to receive the latest news and ratings for MIST and its competitors with MarketBeat's FREE daily newsletter.


Milestone Pharmaceuticals (NASDAQ:MIST) Frequently Asked Questions

What is Milestone Pharmaceuticals' stock symbol?

Milestone Pharmaceuticals trades on the NASDAQ under the ticker symbol "MIST."

How were Milestone Pharmaceuticals' earnings last quarter?

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) released its earnings results on Wednesday, November, 13th. The company reported ($0.52) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.49) by $0.04. View Milestone Pharmaceuticals' Earnings History.

When is Milestone Pharmaceuticals' next earnings date?

Milestone Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for Milestone Pharmaceuticals.

What price target have analysts set for MIST?

6 Wall Street analysts have issued twelve-month price targets for Milestone Pharmaceuticals' shares. Their forecasts range from $26.50 to $32.00. On average, they anticipate Milestone Pharmaceuticals' stock price to reach $29.50 in the next year. This suggests a possible upside of 42.3% from the stock's current price. View Analyst Price Targets for Milestone Pharmaceuticals.

What is the consensus analysts' recommendation for Milestone Pharmaceuticals?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Milestone Pharmaceuticals in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Milestone Pharmaceuticals.

Has Milestone Pharmaceuticals been receiving favorable news coverage?

News coverage about MIST stock has been trending extremely negative recently, according to InfoTrie Sentiment. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Milestone Pharmaceuticals earned a media sentiment score of -4.3 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Milestone Pharmaceuticals.

Are investors shorting Milestone Pharmaceuticals?

Milestone Pharmaceuticals saw a increase in short interest during the month of January. As of January 15th, there was short interest totalling 15,200 shares, an increase of 19.7% from the December 31st total of 12,700 shares. Based on an average daily volume of 18,600 shares, the days-to-cover ratio is presently 0.8 days. Currently, 0.1% of the shares of the company are short sold. View Milestone Pharmaceuticals' Current Options Chain.

Who are some of Milestone Pharmaceuticals' key competitors?

What other stocks do shareholders of Milestone Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Milestone Pharmaceuticals investors own include Walt Disney (DIS), Gilead Sciences (GILD), Enterprise Products Partners (EPD), AT&T (T), Verizon Communications (VZ), Amarin (AMRN), CareDx (CDNA), eHealth (EHTH), LYFT (LYFT) and Novavax (NVAX).

Who are Milestone Pharmaceuticals' key executives?

Milestone Pharmaceuticals' management team includes the folowing people:
  • Mr. Joseph G. Oliveto, CEO, Pres & Director (Age 51)
  • Dr. Philippe Douville, Founder & Chief Scientific Officer (Age 57)
  • Mr. Timothy L. Maness, VP of Fin. (Age 59)
  • Dr. Francis Plat, Chief Medical Officer (Age 61)
  • Mr. Lorenz Muller, Chief Commercial Officer (Age 55)

When did Milestone Pharmaceuticals IPO?

(MIST) raised $75 million in an IPO on Thursday, May 9th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Jefferies, Cowen and Piper Jaffray acted as the underwriters for the IPO and Oppenheimer & Co. was co-manager.

Who are Milestone Pharmaceuticals' major shareholders?

Milestone Pharmaceuticals' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Oxford Asset Management LLP (0.08%). Company insiders that own Milestone Pharmaceuticals stock include Holdings A/S Novo, Rtw Investments, Lp and Stonepine Capital, LP. View Institutional Ownership Trends for Milestone Pharmaceuticals.

Which major investors are selling Milestone Pharmaceuticals stock?

MIST stock was sold by a variety of institutional investors in the last quarter, including Oxford Asset Management LLP. View Insider Buying and Selling for Milestone Pharmaceuticals.

How do I buy shares of Milestone Pharmaceuticals?

Shares of MIST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Milestone Pharmaceuticals' stock price today?

One share of MIST stock can currently be purchased for approximately $20.73.

How big of a company is Milestone Pharmaceuticals?

Milestone Pharmaceuticals has a market capitalization of $507.79 million. Milestone Pharmaceuticals employs 20 workers across the globe.View Additional Information About Milestone Pharmaceuticals.

What is Milestone Pharmaceuticals' official website?

The official website for Milestone Pharmaceuticals is http://www.milestonepharma.com/.

How can I contact Milestone Pharmaceuticals?

Milestone Pharmaceuticals' mailing address is 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420, MONTREAL A8, H4M 2X6. The company can be reached via phone at 514-336-0444 or via email at [email protected]


MarketBeat Community Rating for Milestone Pharmaceuticals (NASDAQ MIST)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  38 (Vote Underperform)
Total Votes:  72
MarketBeat's community ratings are surveys of what our community members think about Milestone Pharmaceuticals and other stocks. Vote "Outperform" if you believe MIST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MIST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel